CARDIOVASCULAR JOURNAL OF AFRICA • Vol 22, No 6, November/December 2011
AFRICA
305
5.
Lohman TG, Roche AF, Martorell R.
Anthropometric Standardization
Reference Manual.
Champaign, IL: Human Kinetics, 1988.
6.
NCEP. Executive summary of the third report of the National Cholesterol
Education Program (NCEP): expert panel on detection, evaluation, and
treatment of high blood cholesterol in adults (Adult Treatment Panel
III).
J Am Med Assoc
2001;
285
: 2479–2486.
7.
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin
BA,
et al
. Diagnosis and management of the metabolic syndrome: an
American Heart Association/National Heart, Lung, and Blood Institute
Scientific Statement (executive summary).
Circulation
2005;
112
:
e285–e290.
8.
Das M, Pal S, Ghosh A. Synergistic effects of ACE (I/D) and ApoE
(HhaI) gene polymorphisms among the adult Asian Indians with and
without metabolic syndrome.
Diab Res Clin Prac
2009;
86
: e58–61.
9.
Ho SC, Chen YM, Woo JL, Leung SS, Lam TH, Janus ED. Association
between simple anthropometric indices and cardiovascular risk factors.
Int J Obes Relat Metab Disord
2001;
25
: 1689–1697.
10. Deepa M, Farroq S, Datta M, Deepa R, Mohan V. Prevalence of
metabolic syndrome using WHO, ATPIII and IDF definitions in Asian
Indians: the Chennai Urban Rural Epidemiology Study (CURES-34).
Diab Metab Res Rev
2007;
2
3:127–134.
11. Kanjilal S, Shanker J, Rao VS, Khadrinarasimhaih NB, Mukherjee M,
Iyengar SS, Kakkar VV. Prevalence and component analysis of meta-
bolic syndrome: an Indian atherosclerosis research study perspective.
Vasc Hlth Risk Manag
2008;
4
:189–197.
12. Wasir JS, Misra A, Vikram NK, Pandey RM, Gupta R. Comparison of
definitions of the metabolic syndrome in adult Asian Indians.
J Assoc
Physicians India
2008;
56
: 158–164.
13. Tong PC, Kong AP, So WY, Yang X, Ho CS, Ma RC,
et al
. The
usefulness of the International Diabetes Federation and the National
Cholesterol Education Program’s Adult Treatment Panel III defini-
tions of the metabolic syndrome in predicting coronary heart disease
in subjects with type 2 diabetes.
Diabetes Care
2007;
30
:1206–1211.
14. Zabetian A, Hadaegh F, Azizi F. Prevalence of metabolic syndrome in
Iranian adult population, concordance between the IDF with the ATP-III
and the WHO definitions.
Diab Res Clin Prac
2007;
77
: 251–257.
It's the
shell that
makes
safer.
R
Safety-Coated
R
81mg
The ORIGINAL low dose aspirin
for optimum cardio-protection
Hp
Each tablet contains Aspirin 81mg. Reg.No.: 29/2.7/0767
Pharmafrica (Pty) Ltd, 33 Hulbert Road, New Centre, Johannesburg 2001
Under licence from Goldshield Pharmaceuticals Ltd. U.K.
